Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study

Precision medicine aims to treat an individual based on their clinical characteristics. A differential drug response, critical to using these features for therapy selection, has never been examined directly in type 2 diabetes. We tested two hypotheses: 1) individuals with BMI>30kg/m(2), compared...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nat Med
Hlavní autoři: Shields, Beverley M, Dennis, John M, Angwin, Catherine D, Warren, Fiona, Henley, William E, Farmer, Andrew J, Sattar, Naveed, Holman, Rury R, Jones, Angus G, Pearson, Ewan R, Hattersley, Andrew T
Médium: Artigo
Jazyk:Inglês
Vydáno: 2023
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7614216/
https://ncbi.nlm.nih.gov/pubmed/36477733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02120-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky